Search

Search Results
Results 16821 - 16830 of 17224 for Active treatment
  • Raman Spectroscopy: Process Analytical Technology for Crystallization Monitoring and Control
    White Paper - 22 Aug 2019
    Pharmaceutical manufacturing and quality control processes are stuck in the past. Process Analytical Technology (PAT) can bring production systems up-to-date and help realize manufacturing efficiency...
  • Intracellular Receptor Signaling for Cancer Research
    White Paper - 6 Aug 2019
    Intracellular receptor signaling for cancer research has been able to demonstrate increased links between dysregulation and increased cancer malignancies.
  • Growth Factor Receptor Signaling for Cancer Research
    White Paper - 6 Aug 2019
    Growth factor receptor signaling for cancer research focuses on the dysfunctional regulation of cancer cells that causes the runaway growth of the cells.
  • A Review of Epigenetics
    White Paper - 2 Aug 2019
    Separate from the underlying DNA, epigenetics formed by the changes in chromatin structure which alter the accessibility of DNA to transcription machinery.
  • GPCR Regulation of the Vascular System and Dysfunction
    White Paper - 2 Aug 2019
    Despite widespread use of drugs targeting GPCR regulation of the vascular system, cardiovascular disease remains the cause of 30% of deaths globally.
  • Pharmacology of Allosteric G Protein-Coupled Receptors
    White Paper - 23 Jul 2019
    The allosteric nature of G protein-coupled receptors transduce signals from spatially distinct binding sites of a the protein.
  • Kloxema cream
    Drug - 19 Jul 2019
    Consumer Medicine Information (CMI) about Kloxema cream (Clobetasone butyrate 0.05 % w/w) intended for persons living in Australia.
  • Exostosis / Osteoma - Benign Overgrowth of Pre-Existing Bone
    Health - 12 Jul 2019
    An exostosis, also called an osteoma, is a benign overgrowth of a pre-existing bone. It forms during the active growth stage. In the majority of cases the bone overgrowth is capped with cartilage, and...
  • Resolve Plus 1%
    Drug - 12 Jul 2019
    Consumer Medicine Information (CMI) about Resolve Plus 1% (Hydrocortisone, miconazole nitrate) intended for persons living in Australia.
  • What is Triclosan and Why is it Banned?
    Health - 2 Jul 2019
    On September 9, 2016, the United States Food and Drug Administration (FDA) banned the incorporation of triclosan and 18 other antimicrobial chemicals from household soap products and the next year...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback